| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.17B | 38.62B | 39.34B | 38.43B | 41.31B | 33.19B |
| Gross Profit | 9.01B | 9.33B | 9.79B | 11.64B | 12.22B | 8.32B |
| EBITDA | 4.57B | 4.98B | 6.15B | 8.28B | 8.77B | 5.09B |
| Net Income | -533.84M | 285.59M | 1.88B | 3.21B | 3.85B | 1.22B |
Balance Sheet | ||||||
| Total Assets | 90.58B | 89.89B | 91.06B | 83.62B | 81.32B | 68.63B |
| Cash, Cash Equivalents and Short-Term Investments | 17.70B | 18.71B | 24.54B | 18.56B | 18.52B | 14.32B |
| Total Debt | 35.11B | 33.65B | 34.01B | 30.84B | 27.84B | 26.14B |
| Total Liabilities | 46.05B | 44.67B | 44.02B | 40.44B | 41.09B | 34.86B |
| Stockholders Equity | 36.24B | 37.05B | 38.71B | 35.90B | 33.12B | 27.89B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.59B | 3.75B | 51.37M | 3.10B | -2.22B |
| Operating Cash Flow | 0.00 | 2.30B | 8.24B | 5.86B | 8.76B | 2.71B |
| Investing Cash Flow | 0.00 | -6.31B | -3.99B | -6.52B | -5.18B | -5.39B |
| Financing Cash Flow | 0.00 | -1.71B | 1.10B | 1.30B | 382.83M | 870.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥309.99B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
77 Outperform | ¥293.96B | 17.58 | ― | 1.49% | 18.20% | 28.13% | |
74 Outperform | ¥571.27B | 44.29 | 4.03% | 2.25% | 3.97% | -41.76% | |
70 Outperform | ¥94.16B | 10.19 | ― | 3.02% | -14.47% | -26.11% | |
62 Neutral | ¥430.49B | 19.19 | 5.63% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥19.38B | 10.83 | 1.29% | 4.91% | -1.71% | ― |